Binimetinib

Spécifications

606143-89-9Numéro CAS

639-995-7Numéro CE

6-(4-bromo-2-fluoroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamideNom IUPAC

C17H15BrF2N4O3Formule chimique

441.2 g/molMasse molaire

Binimetinib; 606143-89-9; MEK162; ARRY-162; Mektovi; 5-[(4-Bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide; MEK-162; ARRY-438162; NVP-MEK162; ARRY 438162; binimetinibum; 181R97MR71; CHEBI:145371; DTXSID70209422; 5-[(4-bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-1,3-benzodiazole-6-carboxamide; 6-[(4-bromo-2-fluorophenyl)amino]-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide; 5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-1,3-benzodiazole-6-carboxamide; 5-((4-BROMO-2-FLUOROPHENYL)AMINO)-4-FLUORO-N-(2-HYDROXYETHOXY)-1-METHYL-1H-BENZIMIDAZOLE-6-CARBOXAMIDE; 6-((4-bromo-2-fluorophenyl)amino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide; RefChem:58059; DTXCID90131913; L01XE41; Binimetinib (MEK-162); MFCD22124525; ARRY 162; MEK162 (ARRY-162, ARRY-438162); 6-(4-bromo-2-fluoroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide; 5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide; Binimetinib (MEK162, ARRY-162, ARRY-438162); 5-(4-Bromo-2-fluoroanilino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide; C17H15BrF2N4O3; Binimetinib (MEK162); Binimetinib [USAN:INN]; UNII-181R97MR71; Mektovi (TN); ARRY-162; ARRY-438162; MEK 162; ARRY 162; ARRY 438162; Binimetinib; Mek162; Binimetinib (Standard); MEK162(Binimetinib); BINIMETINIB [MI]; MEK162(Binimetinib)?; BINIMETINIB [INN]; BINIMETINIB [JAN]; BINIMETINIB [USAN]; BINIMETINIB [WHO-DD]; MLS006011180; SCHEMBL570088; Binimetinib (JAN/USAN/INN); GTPL7921; orb1305378; CHEMBL3187723; SCHEMBL29363187; BINIMETINIB [ORANGE BOOK]; MEK 162; ACWZRVQXLIRSDF-UHFFFAOYSA-N; ARRY-162,MEK-162; BDBM520649; GLXC-04704; HMS3652J14; HMS3747G09; HMS5085L10; EX-A1024; EBC-17109; HY-15202R; NSC764042; NSC788187; NSC799361; s7007; AKOS026750517; CCG-269133; CS-0627; DB11967; FM65077; NSC-764042; NSC-788187; NSC-799361; SB16501; NCGC00345804-01; NCGC00345804-08; NCGC00345804-10; 1073666-70-2; 5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide.; AC-29023; AS-16706; BP-43628; DA-35030; HY-15202; N-(2-hydroxyethoxy)-4-fluoro-5-(2-fluoro-4-bromophenylamino)-1-methyl-1H-benzoimidazole-6-carboxamide; SMR004702949; SY284756; cas:606143-89-9;MEK162; A6971; NS00072273; SW219910-1; D10604; EN300-7411873; F979736; Binimetinib;MEK-162; ARRY-162;ARRY-438162; BRD-K82244583-001-01-3; Q19903515; US11147816, Binimetinib (ARRY-162, ARRY-438162); 1H-Benzimidazole-6-carboxamide, 5-[(4-bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-; 5-(4-Bromo-2-fluoroanilino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-1,3-benzimidazole-6-carboxamide; 5-(4-Bromo-2-fluorophenylamino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide; 5-[(4-Bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methylbenzimidazole-6-carboxamide; 6-(4-bromo-2-fluoro-anilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-benzimidazole-5-carboxamide; 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethyoxy)-amide; QO7Synonymes